SIGA Technologies, Inc.

Common Stock SEC Reporting - Current
OTC Pink Current Information
Verified Company Profile 10/12/2016
Contact Info
  • 660 Madison Avenue
  • Suite 1700
  • New York, NY 10065

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001010086
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1995
Employees 34 a/o Feb 16, 2015
Company Officers/Contacts
Eric A. Rose CEO
Daniel J. Luckshire CFO, EVP, EVP, Fin.
Dennis E. Hruby CSO
Company Directors
Eric A. Rose Chairman
James J. Antal
Michael J. Bayer
Thomas E. Constance
Joseph W. Marshall, III
Jeffrey B. Kindler
Paul G. Savas
Bruce Slovin
Andrew L. Stern
Company Notes
  • Note = On September 16, 2014, the company filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York , Case No. 14-12623.
  • Formerly=SIGA Pharmaceuticals, Inc. until 2-00
Service Providers
Accounting/Auditing Firm
300 Madison Avenue
24th Floor
New York, NY, 10017
United States

Legal Counsel
Not Available
Investor Relations Firm
KCSA Strategic Communications
880 3rd Avenue
6th Floor
New York, NY, 10022
United States

SIGA Security Details
Share Structure
Market Value1 $176,423,962 a/o Dec 02, 2016
Authorized Shares 600,000,000 a/o Oct 10, 2016
Outstanding Shares 54,284,296 a/o Jul 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.0001
Shareholders of Record 33 a/o Mar 04, 2016
Short Selling Data
Short Interest 382,376 (2.37%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security